Search

Author/Creator Hunter, Samuel F

1. 054 Disability improvement is observed in each functional system in alemtuzumab-treated patients with active RRMS: results from CARE-MS II extension. Issue 6 (24th May 2018)

Authors:
Macdonell, Richard AL; Aburashed, Rany A; Alroughani, Raed; Dive, Dominique; Izquierdo, Guillermo; Kim, Ho-Jin; Lycke, Jan; Pozzilli, Carlo; Sharrack, Basil; Vermersch, Patrick; Wiendl, Heinz; Lysandropoulos, Andreas; Chung, Luke; Daizadeh, Nadia; Hunter, Samuel F
Journal:
Journal of neurology, neurosurgery and psychiatry
Issue:
Volume 89:Issue 6(2018)
Page Start:
A22
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Safety and efficacy of ADS-5102 (amantadine) extended release capsules to improve walking in multiple sclerosis: A randomized, placebo-controlled, phase 2 trial. (April 2019)

Authors:
Cohen, Jeffrey A; Hunter, Samuel F; Brown, Theodore R; Gudesblatt, Mark; Thrower, Ben W; Llorens, Lily; Souza-Prien, Cindy J; Ruby, April E; Chernoff, David N; Patni, Rajiv
Journal:
Multiple sclerosis
Issue:
Volume 25:Number 4(2019)
Page Start:
601
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Satisfaction with alemtuzumab in relapsing multiple sclerosis patients: Results from the real-world PRO-ACT study. Issue 4 (October 2022)

Authors:
Wray, Sibyl; Jacques, Francois; Miller, Tamara A; Nicholas, Jacqueline A; Arroyo, Rafael; Travis, Lori; Khatri, Bhupendra; Chirieac, Magdalena; Gandhi, Roopali; Roesch, Nora; Rodrigues, Amelie; Melas-Melt, Lydie; Rawlings, Andreea M; Hunter, Samuel F
Journal:
Multiple sclerosis journal, experimental, translational and clinical
Issue:
Volume 8:Issue 4(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗